Mechanistic and structural basis for activation of cardiac myosin force production by omecamtiv mecarbil
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Omecamtiv mecarbil is a selective, small-molecule activator of cardiac myosin that is being developed as a potential treatment for heart failure with reduced ejection fraction. Here we determine the crystal structure of cardiac myosin in the pre-powerstroke state, the most relevant state suggested by kinetic studies, both with (2.45 Å) and without (3.10 Å) omecamtiv mecarbil bound. Omecamtiv mecarbil does not change the motor mechanism nor does it influence myosin structure. Instead, omecamtiv mecarbil binds to an allosteric site that stabilizes the lever arm in a primed position resulting in accumulation of cardiac myosin in the primed state prior to onset of cardiac contraction, thus increasing the number of heads that can bind to the actin filament and undergo a powerstroke once the cardiac cycle starts. The mechanism of action of omecamtiv mecarbil also provides insights into uncovering how force is generated by molecular motors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kabsch, W. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909047337 · Cited by 16,463
Epidemiology and risk profile of heart failure
Bui, A. L., Horwich, T. B., & Fonarow, G. C. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.165 · Cited by 2,077
Teerlink, J. R., Clarke, C. P., Saikali, K. G., Lee, J. H., Chen, M. M., Escandon, R. D., Elliott, L., Bee, R., Habibzadeh, M. R., Goldman, J. H., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61219-1 · Cited by 262
Self-citation
Cited by
Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure
Teerlink, J. R., Diaz, R., Felker, G. M., McMurray, J. J. V., Metra, M., Solomon, S. D., Adams, K. F., Anand, I., Arias-Mendoza, A., Biering-Sørensen, T., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2025797 · Cited by 656
Self-citationAdvances in the Genetic Basis and Pathogenesis of Sarcomere Cardiomyopathies
Yotti, R., Seidman, C. E., & Seidman, J. G. (2019) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-083118-015306 · Cited by 168
Porter, J. R., Meller, A., Zimmerman, M. I., Greenberg, M. J., & Bowman, G. R. (2020) · eLife · doi:10.7554/elife.55132 · Cited by 31
Ma, W., You, S., Regnier, M., & McCammon, J. A. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2215836120 · Cited by 12
Porter, J. R., Meller, A., Zimmerman, M. I., Greenberg, M. J., & Bowman, G. R. (2019) · doi:10.1101/2019.12.16.878264
Metadata
- Authors
- Planelles-Herrero, V. J., Hartman, J. J., Robert-Paganin, J., Malik, F. I., & Houdusse, A.
- Venue
- Nature Communications
- Published
- 2017-08-04
- Volume
- 8
- Issue
- 1
- Pages
- 190-190
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2741413018
- Cited by
- 202
- References
- 3
- FWCI
- 10.51
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mechanistic and structural basis for activation of cardiac myosin force production by omecamtiv mecarbil. https://app.cochat.ai/papers/10.1038/s41467-017-00176-5
- The paper
- Planelles-Herrero, V. J., Hartman, J. J., Robert-Paganin, J., Malik, F. I., & Houdusse, A. (2017). Mechanistic and structural basis for activation of cardiac myosin force production by omecamtiv mecarbil. Nature Communications. https://doi.org/10.1038/s41467-017-00176-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.